Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study

Muhammad Khan,1,2 Zhihong Zhao,3 Xianming Li,1 Guixiang Liao1 1Department of Oncology, Shenzhen People’s Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, People’s Republic of China; 2Department of Oncology, First Affiliated Hospital of Anhui Medical Uni...

Full description

Bibliographic Details
Main Authors:	Khan M, Zhao Z, Li X, Liao G
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-11-01
Series:	International Journal of General Medicine
Subjects:	brain metastasis (bm) whole brain radiation therapy (wbrt) non-small cell lung cancer (nsclc) immune checkpoint blockade (icb) combination (combined) therapy
Online Access:	https://www.dovepress.com/anti-pd1-therapy-plus-whole-brain-radiation-therapy-may-prolong-pfs-in-peer-reviewed-fulltext-article-IJGM

Similar Items

Strategies to Preserve Cognition in Patients With Brain Metastases: A Review
by: Tyler P. Robin, et al.
Published: (2018-10-01)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
by: Muhammad Khan, et al.
Published: (2019-03-01)

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study
by: Meng Ni, et al.
Published: (2020-03-01)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
by: Corinna Fritz, et al.
Published: (2018-11-01)

Management Strategies for Large Brain Metastases
by: Nehaw Sarmey, et al.
Published: (2022-02-01)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
by: Yun Hua Lee, et al.
Published: (2020-09-01)

Pheophorbide A–Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD–L1 Expression
by: Qinli Tong, et al.
Published: (2022-11-01)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
by: Ilinca Popp, et al.
Published: (2023-06-01)

The Risk of Hippocampal Metastasis and the Associated High-Risk Factors in 411 Patients With Brain Metastases
by: Peng Xie, et al.
Published: (2022-02-01)

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
by: Guang-Long Ma, et al.
Published: (2023-04-01)

Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review
by: Angelo Luciano, et al.
Published: (2023-11-01)

Current Multimodality Treatments against Brain Metastases from Renal Cell Carcinoma
by: Yoshiyuki Matsui
Published: (2020-10-01)

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases
by: Gabriela Antelo, et al.
Published: (2023-10-01)

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
by: Xueyan Wang, et al.
Published: (2022-10-01)

Different treatment planning strategies for whole-brain radiation therapy with simultaneous integrated boost for multiple brain metastases to protect neurocognitive function with hippocampal sparing
by: Ilknur Harmankaya, et al.
Published: (2022-01-01)

Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
by: Muhammad Khan, et al.
Published: (2020-07-01)

Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions
by: Xiaoliang Wang, et al.
Published: (2023-08-01)

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases
by: Kelly H. Yoo, et al.
Published: (2023-08-01)

Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume
by: Ilinca Popp, et al.
Published: (2021-08-01)

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
by: Marta Barisa, et al.
Published: (2024-04-01)

Strategies for improving the performance of prediction models for response to immune checkpoint blockade therapy in cancer
by: Tiantian Zeng, et al.
Published: (2024-04-01)

Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment
by: Zhixiong Chen, et al.
Published: (2023-01-01)

Review of Current Principles of the Diagnosis and Management of Brain Metastases
by: Alex W. Brenner, et al.
Published: (2022-05-01)

Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases
by: Yuan Xu, et al.
Published: (2022-05-01)

Fractionated Volumetric Modulated Arc Therapy (FVMAT) for Oligometastatic Brain Tumor
by: Chi-Yuan Yeh, et al.
Published: (2023-02-01)

Prevention of Brain Metastases
by: Joseph A. Bovi
Published: (2018-09-01)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
by: Sijia Ren, et al.
Published: (2021-06-01)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
by: Cristina Mantovani, et al.
Published: (2021-11-01)

A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
by: Hongen Kang, et al.
Published: (2023-08-01)

PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity
by: Yan Gu, et al.
Published: (2023-01-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

The Expanding Role of Radiosurgery for Brain Metastases
by: Mark O’Beirn, et al.
Published: (2018-08-01)

Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis
by: Wentao Tian, et al.
Published: (2023-04-01)

Modern cancer therapy: cryoablation meets immune checkpoint blockade
by: Qi Liu, et al.
Published: (2024-02-01)

Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
by: Songlin Liu, et al.
Published: (2023-07-01)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
by: Hua Zhu, et al.
Published: (2022-07-01)

Selecting the Appropriate Radiation Therapy Technique for Extensive Brain Metastases from Tens to Hundreds: Should the Latest Technique Always Be the Best Option?
by: Seok Ho Lee
Published: (2023-10-01)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
by: Elisa De Carlo, et al.
Published: (2022-06-01)

CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells
by: Songyi Park, et al.
Published: (2021-01-01)

Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade
by: Mie Linder Hübbe, et al.
Published: (2020-09-01)